BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35581612)

  • 1. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis.
    Li Bassi G; Gibbons K; Suen JY; Dalton HJ; White N; Corley A; Shrapnel S; Hinton S; Forsyth S; Laffey JG; Fan E; Fanning JP; Panigada M; Bartlett R; Brodie D; Burrell A; Chiumello D; Elhazmi A; Esperatti M; Grasselli G; Hodgson C; Ichiba S; Luna C; Marwali E; Merson L; Murthy S; Nichol A; Ogino M; Pelosi P; Torres A; Ng PY; Fraser JF;
    Crit Care; 2022 May; 26(1):141. PubMed ID: 35581612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of neuromuscular blocking agents uses in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Lyu T; Lee YS; Dhanvijay S; Freebairn R
    Minerva Anestesiol; 2021 Mar; 87(3):341-350. PubMed ID: 33300324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression.
    Shao S; Kang H; Tong Z
    BMJ Open; 2020 Nov; 10(11):e037737. PubMed ID: 33444180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
    Needham CJ; Brindley PG
    Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials.
    Chang W; Sun Q; Peng F; Xie J; Qiu H; Yang Y
    Crit Care; 2020 Feb; 24(1):54. PubMed ID: 32066488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular Blocking Agents for ARDS: A Systematic Review and Meta-Analysis.
    Torbic H; Krishnan S; Harnegie MP; Duggal A
    Respir Care; 2021 Jan; 66(1):120-128. PubMed ID: 32843506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular blockers in early acute respiratory distress syndrome.
    Papazian L; Forel JM; Gacouin A; Penot-Ragon C; Perrin G; Loundou A; Jaber S; Arnal JM; Perez D; Seghboyan JM; Constantin JM; Courant P; Lefrant JY; Guérin C; Prat G; Morange S; Roch A;
    N Engl J Med; 2010 Sep; 363(12):1107-16. PubMed ID: 20843245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular Blocker Use in Critically Ill Children: Assessing Mortality Risk by Propensity Score-Weighted Analysis.
    Daverio M; Sperotto F; Stefani C; Mondardini MC; Tessari A; Biban P; Izzo F; Montani C; Lapi M; Picconi E; Racca F; Marinosci GZ; Savron F; Wolfler A; Amigoni A;
    Crit Care Med; 2022 Mar; 50(3):e294-e303. PubMed ID: 34582423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular blocking agents for acute respiratory distress syndrome.
    Torbic H; Duggal A
    J Crit Care; 2019 Feb; 49():179-184. PubMed ID: 30396789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
    Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
    Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome].
    Lyu G; Wang X; Jiang W; Cai T; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived safety and efficacy of neuromuscular blockers for acute respiratory distress syndrome among medical intensive care unit practitioners: A multicenter survey.
    Torbic H; Bauer SR; Personett HA; Dzierba AL; Stollings JL; Ryder LP; Daniels CE; Caples SM; Frazee EN
    J Crit Care; 2017 Apr; 38():278-283. PubMed ID: 28012426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paediatric Acute Respiratory Distress Syndrome Neuromuscular Blockade study (PAN-study): a phase IV randomised controlled trial of early neuromuscular blockade in moderate-to-severe paediatric acute respiratory distress syndrome.
    Rudolph MW; Slager S; Burgerhof JGM; van Woensel JBM; Alffenaar JC; Wösten-van Asperen RM; de Hoog M; IJland MM; Kneyber MCJ;
    Trials; 2022 Jan; 23(1):96. PubMed ID: 35101098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Paralysis for the Management of ARDS.
    Grawe ES; Bennett S; Hurford WE
    Respir Care; 2016 Jun; 61(6):830-8. PubMed ID: 27094392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Neuromuscular Blockade in Moderate-to-Severe Pediatric Acute Respiratory Distress Syndrome.
    Rudolph MW; Kneyber MCJ; Asaro LA; Cheifetz IM; Wypij D; Curley MAQ;
    Crit Care Med; 2022 May; 50(5):e445-e457. PubMed ID: 35029869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
    Mefford B; Donaldson JC; Bissell BD
    Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological agents for adults with acute respiratory distress syndrome.
    Lewis SR; Pritchard MW; Thomas CM; Smith AF
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD004477. PubMed ID: 31334568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Neuromuscular Blockers in Patients with ARDS in ICU: A Retrospective Study Based on the MIMIC-III Database.
    Pan X; Liu J; Zhang S; Huang S; Chen L; Shen X; Chen D
    J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study.
    Ali HS; Elshafei MS; Saad MO; Mitwally HA; Al Wraidat M; Aroos A; Shaikh N; Ananthegowda DC; Abdelaty MA; George S; Nashwan AJ; Mohamed AS; Khatib MY
    BMC Pulm Med; 2021 Nov; 21(1):354. PubMed ID: 34743710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.